Li R, Qi J, Yang Y, Wu Y, Yin P, Zhou M, Qian Z, LeBaige MH, McMillin SE, Guo H, Lin H (2021) Disease burden and attributable risk factors of Alzheimers disease and dementia in China from 1990 to 2019
If rapid scale-based weight loss under medical supervision for a serious metabolic condition is the goal, a GLP-1 may be appropriate
Exposure to excessive heat or freezing temperatures can denature the protein-based medication, rendering it ineffective

Important safety considerations include: Separate fiber supplements from medications : Take fiber supplements at least 2 hours apart from oral medications to avoid potential interference with absorption Monitor for obstruction symptoms : Severe abdominal pain, inability to pass gas, or vomiting requires immediate medical evaluation, as FDA labels for GLP-1 medications include rare postmarketing reports of intestinal obstruction (ileus) [1] [2] Coordinate with healthcare providers : Patients with inflammatory bowel disease, diverticulitis history, or other gastrointestinal conditions need individualized fiber recommendations Adjust fluid intake appropriately : Follow medical guidance if you have conditions requiring fluid restriction Patients should contact their healthcare provider if gastrointestinal symptoms persist despite dietary modifications, worsen significantly, or include warning signs such as blood in stool, unintentional weight loss beyond expected therapeutic effects, or severe abdominal pain
